TABLE 2.

Details of proton pump inhibitor (PPI) use

	Spontaneous bacterial peritonitis		P
	Yes (n=51)	No (n=102)
Double daily PPI dosing	6 (19); n=31	14 (33); n=43	0.207
PPI-appropriate indications	11 (55); n=20	21 (75); n=28	0.147
Indications	n=31	n=43	0.746
Postesophageal variceal banding	6 (19)	7 (16)
Peptic ulcer disease	7 (23)	3 (7)
Dyspepsia	2 (7)	6 (14)
GERD	1 (3)	3 (7)
Alcoholic gastritis	1 (3)	2 (5)
Helicobacter pylori	1 (3)	2 (5)
Gastroprotection	1 (3)	3 (7)
Other	1 (3)	2 (5)
No documentation	11 (36)	15 (35)

Data presented as n (%) unless otherwise indicated. All patients were taking PPIs (daily versus twice daily) for at least 30 days. Inappropriate use was considered if peptic ulcer disease treatment >3 months, postesophageal variceal banding prophylaxis >2 months, portal hypertension gastritis and ulcer prophylaxis without proper indication. GERD Gastroesophageal reflux disease